Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Rheumatology Research Foundation’s Incoming President Shares Vision for Building the Next 30 Years of Growth

From the College  |  Issue: December 2015  |  December 15, 2015

Q. What is your vision for your presidency?

A. Realizing that federal funding for rheumatology research has diminished substantially over the past decade, that our workforce is aging and that our patient population is aging and growing, I want to put my emphasis over the next couple years on expanding the Foundation’s resources. In order to satisfy the needs that we have for funding research and workforce development, we need financial resources. So we must expand our efforts in fundraising. We need to reach out to our patients, our fellow physicians, our fellow rheumatologists and others who have interest in the success of rheumatology research.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Q. What about the Foundation excites you most?

A. The thing that excited me about being involved with the Foundation was realizing that the Foundation is the biggest private funding source of rheumatology research and training in the U.S. As I practice rheumatology and work in my institution, I realize the future of rheumatology depends on having well-trained rheumatology professionals. Our future ability to treat our patients and to conquer our diseases, which is really what we are after—the cure of our diseases—depends on having these advancements in science that the Foundation fosters.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Q. What is your hope for the Foundation over the next 30 years?

A. I wish for greater visibility of the Foundation. I want people to realize that the Foundation is a highly ranked organization that uses the vast majority of its resources for its mission-driven activities—workforce development and research. That realization is what’s behind the Charity Navigator four-star rating, the highest possible, that we have as a foundation.

Q. Why do you believe it’s important for ACR/ARHP members to support the Foundation?

A. The work of the Foundation is fundamental to the success of rheumatology as a discipline and fundamental to the best treatment of our patients. All of us in the ACR/ARHP have this No. 1 goal of making the lives of patients with rheumatic disease better, and the Foundation supports the training and research that make that happen. That’s the key reason why members should support the mission of the Foundation and the work of the Foundation.

We would like to eventually find the cure or cures for these difficult and really devastating diseases, and we want to be able to bring the science necessary for developing these cures to our patients. The Foundation’s work is critical to these goals. We are a long way from the cure for most of our diseases, but we are a lot closer than we were 30 years ago when the Foundation started its work.

Page: 1 2 3 | Single Page
Share: 

Filed under:From the CollegeResearch Rheum Tagged with:ACR/ARHPAssociation of Rheumatology Professionals (ARP)Eric MattesonrheumatologyRheumatology Research Foundation

Related Articles

    Rheum After 5: Dr. Eric Matteson Writes Rheumatic Disease History

    August 12, 2020

    Over the past 20 years, Eric L. Matteson, MD, MPH, emeritus chair, Division of Rheumatology, and emeritus professor of medicine at the Mayo Clinic College of Medicine and Science, Rochester, Minn., as well as a past president of the Rheumatology Research Foundation, has authored or co-authored six books about the history of rheumatic disease and…

    Kussmaul, Meier & Polyarteritis Nodosa

    April 26, 2018

    In 1866, Adolf Kussmaul, an internist, and Rudolf Maier, a pathologist, published the classic characterization of what eventually became known as polyarteritis nodosa.1 It was the first scientific clinical characterization of a noninfectious vasculitis. As such, it became a paradigmatic point of contrast to other types of vasculitides that were later described. Their description also…

    The Tortured Path to the Cortisone Discovery

    February 17, 2019

    CHICAGO—The path to the discovery of cortisone—a top-selling, important drug, with dozens of indications—was complicated by failure, false moves, desperation and obsession. The tale, recounted in the Philip Hench, MD, Memorial Lecture: Crossroads of History & Hope: Discovery & First Use of Cortisone for RA at the 2018 ACR/ARHP Annual Meeting in October, is an…

    The Demise of the Inpatient Rheumatology Unit

    July 19, 2018

    Through much of the 20th century, dedicated rheumatic disease units were found in hospitals across the U.S. and countries around the world. In the latter part of the century, this began to change, with hospitals moving toward the consult model of care for rheumatic patients. This change reflects larger shifts in the medical world toward…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences